Demonstrates mitofusin-2 overexpression protects testis from injury during ischemia-reperfusion, implying potential therapeutic strategies.
This study tested the hypothesis that mitofusin-2 overexpression (Mfn2 Ove ) in adipose-derived mesenchymal stem cells (ADMSC Ove−Mfn2 ) protects the testis against testicular torsion-induced ischemia‒reperfusion (TTIR) injury via AMP-activated protein kinase (AMPK)-mediated mitochondrial dynamic homeostasis. The in vitro results revealed that Mfn2 Ove significantly increased cell viability/mitochondrial content/fusion protein/ATP levels (all P < 0.001). Mfn2 Ove in ADMSCs and GC-1 cells upregulated the expression of mitochondrial fusion proteins/content/OXPHOS complexes/p-AMPK and suppressed fission proteins/autophagy/oxidative stress, which were reversed by siRNA-Mfn2 (all P < 0.001). Compared with the control, Mfn2 Ove significantly increased mitochondrial length in ADMSCs and GC-1 cells ( P < 0.0001). IR activated p-AMPK and upregulated fission proteins, whereas the AMPK inhibitor did not reverse the ability of Mfn2 Ove to upregulate p-AMPK/Mfn2/OPA1/OXPHOS/mitochondrial length in ADMSCs and GC-1 cells ( P < 0.0001). By day 28 after TTIR induction, testicular protein levels of oxidative stress/fibrosis/apoptosis/autophagy/DNA-damage/fission were significantly increased in group 2 (TTIR) compared with those of group 1 (sham-control), whereas the protein levels of mitochondrial fusion/OXPHOS exhibited an opposite pattern of oxidative stress between groups 1 and 2 that were significantly reversed by AMDCs (group 3) and further reversed by ADMSC OVe−Mfn2 (group 4), which was reversed by siRNA-Mfn2 in ADMSCs (group 5) (all P < 0.00001). The p-AMPK protein level significantly increased from groups 1 to 4 but was reversed in group 5 (all P < 0.00001). The cellular levels of androgen receptor/Sertoli cells/alpha-microtubule/vimentin/testis injury score showed identical patterns to those of OXPHOS complexes among the groups (all P < 0.00001). The activation of the AMPK–Mfn2 axis protected the testis against TTIR injury.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: